Saniona saniona.com


Public lists: Pharma Startups (4733)

Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a portfolio of potential drug candidates in pre-clinical and clinical stage including a Phase 3 program for obesity and two Phase 2 programs for metabolic disorders and cocaine addiction, respectively. The research is focused on ion channels – a unique protein class that enables and controls the passage of char...Show all

Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a portfolio of potential drug candidates in pre-clinical and cli...Show all

Company (IPO / Went public)

Phone: +45 70 705 225

Fax:

Baltorpvej 154

Ballerup, DK-2750
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Saniona $0M Jun 15, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Saniona Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tesofensine compositions Sep 07, 2017 Apr 24, 2018 Patent
Phenyl triazole derivative and its use for modulating the gabaa receptor complex Nov 16, 2015 Apr 03, 2018 Patent
Phenyl triazole derivative and its use for modulating the gabaa receptor complex Oct 11, 2016 Feb 06, 2018 Patent
Tesofensine and beta blocker combination formulations Mar 02, 2016 Feb 28, 2017 Patent
Tetrazole derivatives and their use as potassium channel modulators Jun 25, 2013 Jan 31, 2017 Patent
See all 12 patents